XML 41 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Basis of Presentation and Significant Accounting Policies - Schedule of Revenues consist of product sales to customers (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Disaggregation of Revenue [Line Items]    
Total revenues $ 244,317 $ 205,831
NUPLAZID    
Disaggregation of Revenue [Line Items]    
Total revenues 159,721 129,923
DAYBUE    
Disaggregation of Revenue [Line Items]    
Total revenues $ 84,596 $ 75,908